Skip to content

This site uses cookies

By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and enhance user experience. Learn more



Reputation strategy in a REWIRED world

Reputation management has fundamentally shifted in the last decade – from a primary focus on protecting and facilitating business...

Women's Health Strategy - Collectively ensuring women’s voices are heard

The long-awaited Women’s Health Strategy has been published. Its call for evidence in 2021 amassed over 100,000 responses – one of the...

Rewiring corporate strategy to drive resilience

Resilience in reputation has always been important. But in a decade which has already seen a global pandemic, a decline in democracy,...

Innovative contracting at the top of the market access agenda

Pharma and biotech, patients, payers, regulators and HTA agencies gathered at the World Evidence, Pricing and Access Congress in March...

Towards a comprehensive European Mental Health Strategy

Mental health has been on the margins of the European health debate for a long time. Yet, one in six people in the EU, or more than 84...

The future of nanomedicine regulation

Nanomedicine is a complex and diverse term, encompassing the use of nanomaterials for the diagnosis, control, prevention, and...

Is saving our planet "now a communications challenge"?

“Saving our planet is now a communications challenge”.
Sir David Attenborough

We set out to test a hypothesis from Sir...

Climate comms in the age of crisis: PR can bridge the gap

With the war in Ukraine and rising energy prices stirring the beginnings of an anti-green backlash, it’s never been more important to...

Driving diversity, equity and inclusion in the healthcare sector

For all organisations, the need to understand the diversity, equity and inclusion (DE&I) agenda within their workplace – and...

Getting it right the first time: building a value-based contract strategy

The promise of innovative technologies is significant and is welcomed globally. The prospect of new therapies that could save and...

The role of pharma in breaking through the backlog

What should your pharma company talk about for the next twelve months?

It’s a question that many communications and public...

In Conversation with MEP Nicolas Gonzalez Casares

In 2017, former President of the European Commission Jean-Claude Juncker presented his White Paper on the Future of Europe:...